Clinical trial

Predictive Value of Inflammatory Biomarkers and FEV1 for COPD

NCT03532893

StatusCOMPLETED

Study typeOBSERVATIONAL

Start date2018-03-03

PhaseN/A

Study timeline

Study start (actual)2018-03-03Date precision: day

Registry last updated2022-03-29

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

COPDunresolved

FEV1unresolved

Interventions

No interventionOTHER

Sponsors & collaborators

Peking University First Hospitallead sponsor

The Second Hospital of Hebei Medical Universitycollaborator

Henan Provincial People's Hospitalcollaborator

Second Hospital of Jilin Universitycollaborator

First Affiliated Hospital Xi'an Jiaotong Universitycollaborator

Shandong Provincial Hospitalcollaborator

Shanxi Dayi Hospitalcollaborator

Tianjin Medical University General Hospitalcollaborator

The Affiliated Hospital of Inner Mongolia Medical Universitycollaborator

The First Hospital of Qinhuangdaocollaborator

Mapped research locations

BeijingBeijing Municipality, China1 JinanShandong, China1 ZhengzhouHenan, China1 TianjinTianjin Municipality, China1 ChangchunJilin, China1

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT03532893 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.